Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Viridian Therapeutics, Inc.\DEexh_321.htm
EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DEexh_311.htm
EX-10.29 - EXHIBIT 10.29 - Viridian Therapeutics, Inc.\DEexh_1029.htm
EX-10.28 - EXHIBIT 10.28 - Viridian Therapeutics, Inc.\DEexh_1028.htm
EXCEL - IDEA: XBRL DOCUMENT - Viridian Therapeutics, Inc.\DEFinancial_Report.xls
10-K - FORM 10-K - Viridian Therapeutics, Inc.\DEf10k_032615.htm
EX-31.2 - EXHIBIT 31.2 - Viridian Therapeutics, Inc.\DEexh_312.htm
Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

Signal Genetics, Inc.
Carlsbad, California
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No.333-197316) of Signal Genetics, Inc.  Inc. of our report dated March 27, 2015, relating to the consolidated financial statements which appears in this Annual Report on Form 10-K for the year ended December 31, 2014.

New York, New York
March 27, 2015